Prognostic immune scoring of colorectal cancer liver metastasis with MHC class-I expression combined to T cell quantification.

3586Background: Approximately 80% of patients recur after curative-intent resection of colorectal cancer liver metastasis (CRLM) and systemic chemotherapy. Immune profiling may help prognostication...